This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Novo Nordisk A/S (NVO)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 2.03B 0.00 2.34B 2.14B
Receivables 2.81B 2.41B 2.20B 1.63B
Inventories 1.77B 1.69B 1.65B 1.73B
Other Current Assets 281.52M 165.01M 8.38M 428.67M
Total Current Assets 7.78B 7.12B 6.91B 6.65B
Property, Plant & Equipment, Gross 8.15B 7.55B 7.04B 6.82B
Accumulated Depreciation & Depletion 4.10B 3.73B 3.39B 3.16B
Property, Plant & Equipment, Net 4.05B 3.82B 3.65B 3.66B
Intangibles 298.92M 264.97M 259.88M 247.61M
Other Non-Current Assets 101.98M 40.41M 47.65M 52.98M
Total Non-Current Assets 5.23B 4.52B 4.38B 4.30B
Liabilities & Shareholder Equity
Total Assets 13.02B 11.64B 11.29B 10.95B
Accounts Payable 757.39M 683.97M 574.39M 518.40M
Short Term Debt 39.79M 88.62M 61.26M 306.83M
Other Current Liabilities 3.69B 3.06B 2.99B 2.47B
Total Current Liabilities 4.48B 3.84B 3.63B 3.30B
Long Term Debt 0.00 0.00 87.62M 89.91M
Deferred Income Taxes 124.38M 129.74M 559.55M 511.09M
Other Non-Current Liabilities 531.39M 472.70M 482.23M 462.39M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 655.77M 602.44M 1.13B 1.06B
Total Liabilities 5.14B 4.44B 4.76B 4.36B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 7.88B 7.20B 6.54B 6.59B
Common Par 101.80M 99.25M 101.23M 107.03M
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 7.61B 6.91B 6.48B 6.44B
Treasury Stock -3.89M -3.01M -4.19M -4.99M
Other Equity Adjustments 167.14M 192.84M -38.22M 52.80M
Total Capitalization 7.88B 7.20B 6.62B 6.68B
Total Equity 7.88B 7.20B 6.54B 6.59B
Total Liabilities & Stock Equity 13.02B 11.64B 11.29B 10.95B
Total Common Shares Outstanding 2.75B 2.37B 2.47B 2.57B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 425.00M 0.00 0.00
Basic Weighted Shares Outstanding 2.68B 2.74B 2.83B 2.90B
Diluted Weighted Shares Outstanding 2.69B 2.76B 2.85B 2.93B
Number of Employees NA 34286 32000 30483
Number of Part-Time Employees NA 0 0 0
NVO News

NVO Novo Nordisk A/S

Analysts Ratings for NVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1

Brokerage Partners

NVO Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs